Funds and ETFs Pharmaron Beijing Co., Ltd.
Equities
300759
CNE100003JW4
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.96 CNY | -1.82% | +1.06% | -31.12% |
Apr. 30 | Pharmaron Beijing's Profit Rises 17% in 2023 | MT |
Apr. 29 | Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy | MT |
ETFs positioned on Pharmaron Beijing Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.17% | 0 M€ | -13.40% | - | |
0.13% | 35 M€ | -5.85% | - | |
0.10% | 0 M€ | +2.32% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 4 M€ | -11.56% | ||
0.03% | 7 M€ | -.--% | - | |
0.01% | 0 M€ | +2.96% | - | |
0.01% | 0 M€ | +8.41% | - | |
0.01% | 0 M€ | +7.38% | - | |
0.01% | 0 M€ | +5.56% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +4.06% | - | |
0.00% | 0 M€ | +2.91% | - | |
0.00% | 0 M€ | +14.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.12% | 4.58B | |
+22.36% | 46.4B | |
-1.68% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.93% | 26.01B | |
-19.11% | 19.52B | |
+28.90% | 12.43B | |
+0.18% | 12.18B | |
-0.54% | 12.13B |
- Stock Market
- Equities
- 300759 Stock
- Funds and ETFs Pharmaron Beijing Co., Ltd.